Last reviewed: September 22, 2025 What this article covers: why the psychedelic facilitator–client relationship is often more important than the medicine itself, what training and qualities matter most, how cultural fit shapes outcomes, and how seekers can evaluate...
FDA Publishes MDMA CRL, Exposes Safety and Durability Concerns for Psychedelic Therapies The US Food and Drug Administration announced on September 4, 2025 that it will publish Complete Response Letters promptly after they are issued, and it released a batch of 89...
Why this matters: Microdosing psychedelics has grown from subculture practice to mainstream wellness trend, but rigorous clinical evidence is sparse and safety signals are emerging. This explainer summarizes current gaps, recent concerns, and practical steps for...
Single dose of MM120 (LSD) shows lasting reduction in generalized anxiety disorder, JAMA reports Why this matters: A randomized, placebo-controlled Phase 2b trial published in JAMA found that a single oral dose of MM120, an investigational LSD formulation,...
